These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33804181)

  • 1. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.
    Dlamini Z; Alaouna M; Mbatha S; Bhayat A; Mabongo M; Chatziioannou A; Hull R
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
    Wang Y; Wang J; Huang Y
    Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
    Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
    Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of hub genes and potential therapeutic mechanisms related to HPV positive head and neck squamous carcinoma based on full transcriptomic detection and ceRNA network construction.
    Wang K; Zhang T; Li X; Zhang X; Li R; Pan B; Deng J
    Gene; 2024 Jun; 910():148321. PubMed ID: 38428621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
    Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct co-expression networks using multi-omic data reveal novel interventional targets in HPV-positive and negative head-and-neck squamous cell cancer.
    Costa RL; Boroni M; Soares MA
    Sci Rep; 2018 Oct; 8(1):15254. PubMed ID: 30323202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
    Messerschmidt C; Obermayer B; Klinghammer K; Ochsenreither S; Treue D; Stenzinger A; Glimm H; Fröhling S; Kindler T; Brandts CH; Schulze-Osthoff K; Weichert W; Tinhofer I; Klauschen F; Keilholz U; Beule D; Rieke DT
    Int J Cancer; 2020 Oct; 147(8):2293-2302. PubMed ID: 32468570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma.
    Broutian TR; Jiang B; Li J; Akagi K; Gui S; Zhou Z; Xiao W; Symer DE; Gillison ML
    Cancer Lett; 2020 Apr; 476():23-33. PubMed ID: 31958486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
    Liu C; Guo T; Xu G; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Khan Z; Fisch KM; Califano J
    Clin Cancer Res; 2018 Oct; 24(20):5123-5132. PubMed ID: 29945995
    [No Abstract]   [Full Text] [Related]  

  • 12. HPV Meets APOBEC: New Players in Head and Neck Cancer.
    Riva G; Albano C; Gugliesi F; Pasquero S; Pacheco SFC; Pecorari G; Landolfo S; Biolatti M; Dell'Oste V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YRNAs: New Insights and Potential Novel Approach in Head and Neck Squamous Cell Carcinoma.
    Guglas K; Kolenda T; Stasiak M; Kopczyńska M; Teresiak A; Ibbs M; Bliźniak R; Lamperska K
    Cells; 2020 May; 9(5):. PubMed ID: 32455790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Transcript-Based Biomarkers Predicting Clinical Outcomes of HPV-Positive Head and Neck Squamous Cell Carcinoma Patients.
    Muñoz-Bello JO; Romero-Córdoba SL; García-Chávez JN; González-Espinosa C; Langley E; Lizano M
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
    Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
    Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and gene mutations in head and neck squamous carcinomas.
    Friedland P; Thomas A; Naran A; Amanuel B; Grieu-Iacopetta F; Carrello A; Harnett G; Meyer C; Phillips M
    ANZ J Surg; 2012 May; 82(5):362-6. PubMed ID: 22507644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of head and neck squamous cell carcinoma.
    Saada-Bouzid E; Peyrade F; Guigay J
    Curr Opin Oncol; 2019 May; 31(3):131-137. PubMed ID: 30893149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
    Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
    Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.